Vericel Corp (VCEL) – Strategy, SWOT and Corporate Finance Report

Vericel Corp – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vericel Corp (Vericel) develops and markets advanced cell therapies for sports medicine and severe burn care domain. Its major products include MACI (autologous cultured chondrocytes on porcine collagen membrane) for the treatment of cartilage defects; and Epicel cultured epidermal autografts for skin replacement. It also holds an exclusive license for NexoBrid in North America for the treatment of severe thermal burns. It has cell manufacturing facility in. The company sells its products through clinical support specialists. Vericel is headquartered in Cambridge, Massachusetts, the US.

Scope

• Detailed information on Vericel Corp required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Vericel Corp in the form of a SWOT analysis

• An in-depth view of the business model of Vericel Corp including a breakdown and examination of key business segments

• News about Vericel Corp, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Vericel Corp and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Vericel Corp as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Vericel Corps business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Zimmer Biomet Holdings Inc

Avita Medical Americas LLC

Arthrex Inc

Anika Therapeutics Inc

AlloSource

Aesculap Biologics LLC

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Vericel Corp - Key Facts

Vericel Corp - Key Employees

Vericel Corp - Key Employee Biographies

Vericel Corp - Major Products and Services

Vericel Corp - History

Vericel Corp - Company Statement

Vericel Corp - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Vericel Corp - Business Description

Product Category: Epicel

Overview

Performance

Product Category: MACI

Overview

Performance

R&D Overview

Vericel Corp - Corporate Strategy

Vericel Corp - SWOT Analysis

SWOT Analysis - Overview

Vericel Corp - Strengths

Vericel Corp - Weaknesses

Vericel Corp - Opportunities

Vericel Corp - Threats

Vericel Corp - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Vericel Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020

Vericel Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020

Vericel Corp, Recent Deals Summary

Section 5 – Company’s Recent Developments

Apr 02, 2020: Vericel provides business and financial updates

Feb 25, 2020: Vericel reports fourth quarter and full-year 2019 financial results and provides full-year 2020 financial guidance

Nov 06, 2019: Vericel announces appointment of Sean C. Flynn as Vice President and General Counsel

Nov 05, 2019: Vericel reports record third quarter revenues, net income and operating cash flow

Aug 06, 2019: Vericel reports second quarter 2019 financial results and raises full year 2019 Revenue Guidance

May 07, 2019: Vericel reports first quarter 2019 financial results and raises full year 2019 revenue guidance

Feb 26, 2019: Vericel announces fourth quarter and full-year 2018 financial results

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Vericel Corp, Key Facts

Vericel Corp, Key Employees

Vericel Corp, Key Employee Biographies

Vericel Corp, Major Products and Services

Vericel Corp, History

Vericel Corp, Other Locations

Vericel Corp, Subsidiaries

Vericel Corp, Key Competitors

Vericel Corp, Ratios based on current share price

Vericel Corp, Annual Ratios

Vericel Corp, Annual Ratios (Cont…1)

Vericel Corp, Interim Ratios

Vericel Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020

Vericel Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020

Vericel Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Vericel Corp, Performance Chart (2015 – 2019)

Vericel Corp, Ratio Charts

Vericel Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020

Vericel Corp, Medical Equipment, Deals by Type, 2014 to YTD 2020

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports